Can a New Mexico resident get peptides by telehealth?
The New Mexico Telehealth Act defines telehealth to include interactive audio, video, and data communications as well as store-and-forward technologies, but it also says the Act does not authorize care in a manner not otherwise authorized by law, so prescribing standards come from each licensing board. For physicians and physician assistants, New Mexico Medical Board rule 16.10.8.8(L) NMAC makes it unprofessional conduct to prescribe without an established physician-patient relationship, including prescribing over the internet based solely on an online questionnaire. Rule 16.10.8.7 says the relationship is established, at a minimum, by an interactive encounter with an appropriate history and examination, and the only telehealth exception in 16.10.8.8(L)(6) is a face-to-face telehealth encounter using standard videoconferencing technology. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as not allowed, because the Medical Board rule recognizes only a live videoconference encounter as the telehealth route to prescribing for a new patient. That is a reading of the rule, which does not use the word asynchronous. The rules of other prescriber boards, such as nursing, were not reviewed. [4] [5] [6] [7]
How does the New Mexico pharmacy board treat compounding?
| Board | New Mexico Board of Pharmacy (Regulation and Licensing Department) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The New Mexico Board of Pharmacy regulates pharmacy under the Pharmacy Act (NMSA 1978, sections 61-11-1 and following) and Title 16, Chapter 19 of the New Mexico Administrative Code. 16.19.36 NMAC governs compounded sterile preparations: it requires facilities, environmental monitoring, and written procedures consistent with USP chapter 797, sets minimum dedicated compounding space, and requires training of everyone who performs or oversees sterile compounding. The Board inspects sterile compounders by risk category and uses a separate nonresident sterile pharmacy application for out-of-state pharmacies that ship sterile preparations into New Mexico. Under the Pharmacy Act, NMSA 1978 section 61-11-2 defines a nonresident pharmacy as any pharmacy located outside New Mexico that ships, mails, or delivers drugs into New Mexico, and section 61-11-14 requires anyone who engages in an activity in the state requiring Board licensure to obtain the proper license, listing nonresident pharmacy as a license class. New Mexico has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [2] [3] [8] [9] [13]
Can you get compounded GLP-1s in New Mexico?
Because compounded GLP-1 injections are sterile preparations, an out-of-state pharmacy shipping them into New Mexico must hold the Board's nonresident sterile licensure and meet 16.19.36 NMAC standards. [8] [9] [16]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in New Mexico?
Access options
Prescriber licensed in New Mexico, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in New Mexico. Expect a live video or phone visit; prescribing without one is not permitted. State law says an online questionnaire alone is not enough.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in New Mexico
What you'll actually find in New Mexico, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [20] [21] [22]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [23]
What New Mexico has done
PeptideAgent has not found a board or legislative action on peptides in New Mexico.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [25] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [26] [27] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in New Mexico. Expect a live video or phone visit; prescribing without one is not permitted. State law says an online questionnaire alone is not enough. [4] [5] [6] [7] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the New Mexico Board of Pharmacy (Regulation and Licensing Department); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [24]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [23]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [14] [28] [29]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [24] [30] [31]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [22] [31] [32]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [23] [33] [34] [35] [36] [37]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [23]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [24]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [22]
- Pharmacy: Is this made for me on a prescription written in my name? [32]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [22] [31]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [22]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in New Mexico?
The New Mexico Drug, Device and Cosmetic Act (NMSA 1978, sections 26-1-1 and following) prohibits selling adulterated or misbranded drugs and limits dispensing of dangerous drugs to licensed practitioners and pharmacies. [10] [17]
Peptide-specific notes for New Mexico
| Peptide | Note |
|---|---|
| Tirzepatide | Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and any compounded injection must be prepared under 16.19.36 NMAC or an equivalent nonresident sterile license. [8] [16] |
Frequently asked questions
Can I get a GLP-1 prescription in New Mexico through telehealth?
Yes, from a New Mexico-licensed prescriber. Semaglutide and tirzepatide are not controlled substances. The New Mexico Telehealth Act leaves the prescribing standard to the prescriber's licensing board. For physicians and physician assistants, New Mexico Medical Board rule 16.10.8.8(L) NMAC does not allow prescribing based solely on an online questionnaire, and its only telehealth exception is a face-to-face encounter using standard videoconferencing technology. A new telehealth patient should expect a live video visit. [4] [6] [7] [11]
Does the New Mexico Telehealth Act let out-of-state providers treat me without a New Mexico license?
No. Section 24-25-5(A) says the Telehealth Act does not alter any provider's scope of practice or authorize care in a manner not otherwise authorized by law. A physician who treats a patient in New Mexico still needs a New Mexico license, which can be a telemedicine license, unless a narrow exception in the Medical Practice Act applies. [6] [11] [12]
Can an out-of-state pharmacy ship compounded injectable peptides to me in New Mexico?
Only if it holds New Mexico nonresident licensure, and for sterile preparations such as injectable peptides the Board uses a separate nonresident sterile application. Check the Board's license lookup before ordering. [1] [3] [9]
Can a New Mexico pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: New Mexico has no state bulks list; peptide eligibility follows the federal 503A framework. [13] [14] [15] [18] [19]
From the blog
- Can you get a GLP-1 through telehealth in your state?
Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with state examples.
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]New Mexico Board of Pharmacy (Regulation and Licensing Department)
- [2]NMSA 1978, section 61-11-2, Pharmacy Act definitions (nonresident pharmacy)
- [3]NMSA 1978, section 61-11-14, Pharmacy licensure; classes of licenses; requirements; fees; revocation
- [4]New Mexico Telehealth Act, NMSA 1978, Chapter 24, Article 25
- [5]NMSA 1978, section 24-25-3, Telehealth Act definitions
- [6]NMSA 1978, section 24-25-5, Telehealth Act scope of act
- [7]16.10.8 NMAC, Medical Ethics (New Mexico Medical Board), including 16.10.8.7 and 16.10.8.8(L)
- [8]16.19.36 NMAC, Compounded sterile preparations
- [9]New Mexico Board of Pharmacy: nonresident sterile pharmacy application (2022)
- [10]New Mexico Drug, Device and Cosmetic Act, NMSA 1978, Chapter 26, Article 1
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in New Mexico?. https://peptideagent.ai/legal/new-mexico- HTML link
<a href="https://peptideagent.ai/legal/new-mexico">Are peptides legal in New Mexico?</a>, PeptideAgent, updated October 28, 2026.